Rare diseases
Investigational molecules
Locations
500 Kendall Street, 02142-1108, United States
Takeda Development Center Americas Inc. funds research in ulcerative colitis, Crohn’s disease, chronic pouchitis, and complex perianal fistulas, with additional interest in pediatric and adult disease activity, mucosal healing, and remission outcomes. Its portfolio also includes studies in gastroesophageal reflux disease and erosive esophagitis, extending into pediatric gastrointestinal care.
The sponsor’s gastrointestinal research spans both adult and pediatric populations, including refractory and moderate-to-severe inflammatory disease.
Takeda Development Center Americas Inc. runs clinical trials in conditions such as Crohn's disease, Colitis ulcerative, Narcolepsy, Anaemia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
BelgiumStudy of Zasocitinib and Apremilast for Adults with Active Psoriatic Arthritis Who Have Not Used Biologic Medicines
BelgiumStudy on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1
AustriaA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
BelgiumA study to evaluate the effectiveness and safety of zasocitinib in children and adolescents with moderate-to-severe plaque psoriasis
GermanyA Study to Test the Safety and Effectiveness of TAK-360 in People with Narcolepsy without Cataplexy
FranceA Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia to Evaluate Long-term Safety and Effectiveness
BulgariaA Study of Mezagitamab Compared to Placebo for Adults with Chronic Primary Immune Thrombocytopenia
BulgariaLong-term safety study of subcutaneous vedolizumab in children and adolescents with ulcerative colitis or Crohn's disease
BelgiumStudy of Mezagitamab in Adults with Primary IgA Nephropathy (Berger's Disease) to Reduce Protein in Urine
AustriaStudy of human normal immunoglobulin and teclistamab for infection prevention in adults with multiple myeloma receiving B-cell maturation antigen therapy
AustriaComparison of TAK-881 and HyQvia for adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
CzechiaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
